Diana Johnson MP: speeches

Speeches

• 15 Sept 2026 · Sepsis Awareness Month · Hansard source

  More

  I start by congratulating the hon. Member for Kingswinford and South Staffordshire (Mike Wood) on securing this important debate on the Floor of the House of Commons from the Backbench Business Committee during Sepsis Awareness Month. I also thank him for his tireless advocacy on sepsis as the co-chair of the APPG. In his excellent opening speech, he spoke very movingly about his own experience. He said that consultants gave him a 10% chance of survival when he was ill with sepsis, so the odds were that he would not be with us today, but I am very grateful that he is and that he is looking so well, and that he can be such a strong voice in this place on sepsis. I also compliment Lord Mackinlay on the work that he carries on in the other place. Like the shadow Minister, I remember the standing ovation he received when he returned to the House of Commons after battling life-threatening sepsis in 2023, resulting in four limb amputations—what a brave and decent man! Many tributes have been paid to him across the Chamber this afternoon. I will refer to some of the contributions that have been made. My hon. Friend the Member for Dartford (Jim Dickson) spoke powerfully on behalf of his constituent John, who fought sepsis and is a quadruple amputee. He talked very movingly about how the community had rallied around the family to provide support, but also spoke about how we need to do much more to support people like John in the post-recovery period. My hon. Friend the Member for Carlisle (Ms Minns) spoke eloquently about her mum, who she lost to sepsis last year—I hope she will accept my condolences—and also her constituent, Kelly Pattison. She reminded us that sepsis affects people in different ways and how important it is to remember that. The hon. Member for Winchester (Dr Chambers), who speaks on behalf of the Liberal Democrats, highlighted the particular risks that people with cancer face from sepsis. I will certainly take back to the Department the concerns that he has raised today. Sepsis is a devastating condition. It also costs the NHS significant sums of money—more than £1 billion between 2024 and 2025. During Sepsis Awareness Month, I pay tribute to the charities, such as the UK Sepsis Trust and Sepsis Research FEAT, that do so much to support families, raise awareness and fund research. Their contribution to the new sepsis modern service framework was invaluable, and they acted as a megaphone for so many people whose lives have been devastated by sepsis. My deepest condolences go out to everyone who has been affected, not least Merope Mills and other campaigners, but I know that people are not seeking my sympathy today; they want the Government to support the case they are making. Turning to the sepsis modern service framework, we worked hand in hand with patient representatives, clinical experts, professional bodies, NHS organisations and charities to build the framework. It has entered the history books as the first-ever large-scale engagement process for improving sepsis care. The framework spells out this Government’s commitment to transform sepsis care by 2035. It sets out priority actions to improve prevention, recognition, treatment and recovery while accelerating innovation. I completely understand that people will say, “Okay, you have now got the framework. What happens next?” We are going to make real progress, and by doing that, we are going to raise our game in a number of areas, including science, technology and data. The National Institute for Health and Care Research, working with academia, industry and other partners, will develop a national research and innovation action plan for sepsis by March next year. That will include research calls that cover sepsis improvement priorities, whether it is vaccination and screening, faster and more accurate diagnosis or innovative treatments. It is true that the most recent data from the Office for National Statistics suggests that sepsis deaths went down in 2024. However, the data is incomplete and inconsistent. That is due to changes in awareness, diagnosis and recording, making it harder to understand variation and improve care. Without that data, we do not have a full picture, and that is why the framework commits to collecting better sepsis data and why NHS England is commissioning a national infection and sepsis audit. That should give us a clearer picture of mortality, underlying causes and which groups are most affected. Turning to understanding, it is right to say that Members have highlighted that sepsis is a complex condition that is difficult to recognise because of the variation in symptoms. Many people are unaware that sepsis can develop from common infections, such as urinary tract infections, and few can recognise the full range of symptoms. That is precisely why raising awareness is so important. As we have heard from Members across the House today, the work of campaigners has had a huge impact across the NHS and wider society. The NHS now has a planned, targeted public communications campaign to improve awareness of sepsis symptoms and the actions to take.

• 9 Sept 2026 · Pharmacies: Government Funding · Hansard source

  More

  Absolutely, we are. I will set out what we are doing about pharmacy, but I thought it would be useful to reflect on the comments and contributions. First, I want to address the issue of funding. As I said at the outset, the Government recognise the challenges facing community pharmacies following years of underfunding and the difficult fiscal environment. That is why, last year, we took the necessary decisions to give the sector a record 19% funding uplift across ’24-25 and ’25-26. I stress that, at the time, it was the NHS’s largest uplift. However, we know many pharmacies continue to face financial pressures, which is why we have followed last year’s settlement with a further significant uplift of 10% for ’26-27, worth an additional £340 million for the sector. That funding will help to ensure that patients can continue to access medicines and important clinical support from community pharmacists. The uplift will also support the national roll-out of NHS pharmacist prescribing. From autumn ’26, those services will enable pharmacists to prescribe within the existing Pharmacy First and contraception service pathways, and for up to five new pathways. This will deliver increased access to NHS care, relieve pressures on other parts of the NHS and strengthen support in communities across England, delivering on the commitment made in our manifesto. This year’s uplift is almost three times the rate of growth in the overall NHS budget and it demonstrates the priority the Government place on community pharmacy, but I do not pretend that the challenges will disappear overnight. Many pharmacies continue to face financial pressures, but the settlements represent a clear change in direction and provide the foundations for longer-term reform. Numerous Members raised pharmacy closures, and I can tell them that, according to recent data, there were 19 net closures in ’25-26 compared with 112 in ’24-25. There has been some progress, but I recognise that there is a lot more to do. The long-term sustainability of community pharmacy depends on making better use of pharmacists’ clinical skills, reducing unnecessary administrative burdens and enabling pharmacists to deliver more care closer to people’s homes. We will deliver this through the three shifts set out in our 10-year health plan: sickness to prevention, analogue to digital, and hospital to community. Let me give a clear example of how community pharmacy can support the shift from sickness to prevention. As a new Minister, I have already been struck by the vital role community pharmacists play in bringing vaccination services closer to the communities they serve. The NHS vaccination strategy and our 10-year health plan set out a clear ambition to increase vaccine uptake through primary care. That means complementing the core offer from general practice with accessible vaccination services in settings including maternity and sexual health services, schools, health visiting teams and, crucially, community pharmacy. During the ’25-26 flu programme, community pharmacists vaccinated approximately 4.7 million people, around 600,000 more than in the previous year. This demonstrates the growing contribution that pharmacists can make to prevention as a central part of the NHS-commissioned vaccine programme. The shift from analogue to digital is very important. I am well aware that outdated technologies prevent skilled staff across the health and care sector, including pharmacy teams, from working to their full potential, stifling innovation and efficiency. Of course, digital transformation is not just about technology for its own sake; it is about giving pharmacists the tools they need to spend less time on admin and more time on caring for patients, and about giving patients more control over the care and support they receive. Last year, a new prescription tracking service was introduced on the NHS app across nearly 1,500 community pharmacies in England. It allows patients to receive real-time updates and to check when their prescriptions are ready. This year, we will go further by strengthening the digital links between pharmacies and general practice as we build neighbourhood health teams in every community. Digital technology also has an important role to play in strengthening medicine supply chains, which is another issue raised today. We also want prescribers to have better information about medicine shortages. At present, GPs cannot routinely see live national shortage information when prescribing. We intend to make that information available in real time to help GPs to prescribe suitable alternatives where necessary, saving time for patients and neighbourhood health teams. That will mean fewer patients going from pharmacy to pharmacy in search of medicines. Thirdly, if we are serious about shifting care out of hospitals and into communities, community pharmacies must be part of the answer. They are trusted, accessible and highly valuable to the communities they serve. They have enormous potential.

• 9 Sept 2026 · Pharmacies: Government Funding · Hansard source

  More

  As ever, it is a pleasure to serve under your chairmanship, Mr Betts. I congratulate the hon. Member for Leicester East (Shivani Raja) on securing this important debate and on her opening statement, which set out thoroughly the current situation of pharmacies and the challenges that they face. We all agree that community pharmacies are at the heart of the NHS and of their local communities. We absolutely recognise the important role that pharmacies play in delivering health services in neighbourhoods across the country, and the opportunity for that role to keep growing. We also recognise that many community pharmacies face financial pressures and that ensuring financial sustainability for community pharmacies is essential to improve patients’ access to medicines and services. That is why, since coming into office, the Government have delivered successive uplifts to pharmacy funding, following years of cuts or flat funding, and have invested in pharmacies to roll out NHS prescribing and to improve patient access to care in their communities. Of course, none of that would be possible without the dedication and professionalism of pharmacy teams supporting patients across the country. Over the years, like other Members, I have visited many pharmacies in my constituency to listen to what the teams have to say, and I have met with my local organisation Community Pharmacy Humber and its chief executive Paul McGorry. The contributions to the debate have been excellent and very well-informed. My hon. Friend the Member for North Somerset (Sadik Al-Hassan) is the chair of the APPG on pharmacy and a community pharmacist. He talked about his vision of the integration of primary care by 2040, and how important pharmacy is in that. I very much look forward to discussing that with him outside of this debate. We then heard from the right hon. Member for Richmond and Northallerton (Rishi Sunak). I think his mum would be very proud that he is banging the drum for pharmacy. He talked about pharmacies in his rural constituency and the important role that they play in rural areas, which was a common theme in the debate. The hon. Member for Newbury (Mr Dillon), a vice-chair of the APPG on pharmacy, gave a very thoughtful speech outlining the challenges facing pharmacy. The hon. Member for West Dorset (Edward Morello) referenced the closure of the Jhoots stores and highlighted the potential weaknesses in the current regulatory frameworks around closures, which are the reason the Department has been reviewing whether changes are needed to strengthen the oversight of pharmacy businesses. We are actively considering a range of options, including whether legislative changes are required. My officials have been working closely with the General Pharmaceutical Council, NHS England and others to identify any gaps in the current framework. I am of course very happy to meet the hon. Gentleman to discuss that further. We of course heard from the hon. Member for Strangford (Jim Shannon). He talked about pharmacies in Northern Ireland and the effect on pharmacists and their staff of the stress they are under. He also made the economic case for the use of pharmacies. I was very impressed that the hon. Member for South West Hertfordshire (Mr Mohindra) did work experience in a pharmacy, but I was a little concerned that he seems to have forgotten all the cuts that occurred to pharmacy under previous Conservative Governments. I think it is fair to say that they made pharmacy payments practically a fixed contract. In essence, with inflation, that meant there were year-on-year cuts to pharmacy funding. The Liberal Democrat spokesperson, the hon. Member for Mid Sussex (Alison Bennett), spoke about the role of pharmacies and the particular role that they played during covid. We must all remember how important pharmacy staff and pharmacists were during that period; I assure her that I have not forgotten that, and I do not think that the Government have either. The shadow Minister, the hon. Member for Farnham and Bordon (Gregory Stafford), seems to be suffering from amnesia, which is a common problem among Opposition Members when it comes to the funding situation under the Conservative Government.